Who is sponsoring NCT05048173?

NCT05048173 is sponsored by Far Eastern Memorial Hospital.

What drugs are being tested in NCT05048173?

Interventions in NCT05048173: Sentinel lymph node mapping and biopsy, Lymphadenectomy.

What condition does NCT05048173 study?

NCT05048173 studies Early Stage Endometrial Cancer, Sentinel Lymph Nodes, Lymphadenectomy.

Is NCT05048173 still recruiting?

NCT05048173 is currently completed. Last updated 15 September 2023.

Last reviewed 2023-09-15 · How we verify

NCT05048173

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sentinel Lymph Node Biopsy Versus Lymphadenectomy in Endometrial Cancer

Completed Last updated 15 September 2023

What this trial tests

trial testing Sentinel lymph node mapping and biopsy in Early Stage Endometrial Cancer in 334 participants. Completed in 2 June 2022.

Timeline

1 October 2021

Primary endpoint
2 June 2022

2 June 2022

Quick facts

Lead sponsor	Far Eastern Memorial Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	334
Start date	1 October 2021
Primary completion	2 June 2022
Estimated completion	2 June 2022
Sites	1 location across Taiwan

Drugs / interventions tested

Sentinel lymph node mapping and biopsy
Lymphadenectomy

Conditions studied

Early Stage Endometrial Cancer — all drugs for Early Stage Endometrial Cancer →
Sentinel Lymph Nodes — all drugs for Sentinel Lymph Nodes →
Lymphadenectomy — all drugs for Lymphadenectomy →

Sponsor

Far Eastern Memorial Hospital

Who can join

20 and older, female only, with Early Stage Endometrial Cancer or Sentinel Lymph Nodes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare sentinel lymph nodes biopsy versus comprehensive lymphadenectomy in patients with early stage endometrial cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Far Eastern Memorial Hospital trials

Trials by the same sponsor.

NCT07385976 — The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients · not yet recruiting
NCT07107542 — Exploring the Relationship Between Mini-Clinical Evaluation Exercise (Mini-CEX) and Entrustable Professional Activities · not yet recruiting
NCT07114653 — The Role of POLE Mutation in High Risk Endometrial Cancer. · recruiting
NCT07105345 — Exploring Efficacy of Multi-Mode Cognitive Processing Therapy (CPT) for PTSD · NA · recruiting
NCT07110350 — Clinical Outcomes of Non-Indicated Staged Laparotomies in Abdominal Trauma · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05048173 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Far Eastern Memorial Hospital
Last refreshed: 15 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05048173.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing